The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
SEMINAR 11: Paediatrics – handling of drugs in paediatric patients
Affiliation
Honorary Research Fellow, Institute of Translational Medicine (Child Health), University of Liverpool and Industry Professor, School of Pharmacy and Biomedical Sciences, Liverpool John Moores University.
Country
United Kingdom
1. Current Status, Position
- Research Consultant for NIHR Medicines for Children Research Network, University of Liverpool and Alder Hey Children’s Hospital, Liverpool
- Member of the Paediatric Committee, European Medicines Agency
- Investigator or Principal Investigator for several research projects
2. Education
- B Pharm (Hons), Nottingham, UK
- Fellow of the Royal Pharmaceutical Society of Great Britain (FRPharmS)
- Honorary Fellow of the Royal College of Paediatrics and Child Health (FRPCH)
- Retired from the UK National Health Service in December 2010 after 38 years in the NHS and 32 years as Chief Pharmacist and Clinical Director of Pharmacy at Alder Hey Children’s Hospital in Liverpool, UK. Previously a member of the UK Commission on Human Medicines and the EMA Paediatric Working Party. Currently a member of the Paediatric Committee at EMA representing the profession of paediatric pharmacy and an advisor to WHO on essential medicines for children.
3. Research area
His current areas of research include adverse drug reactions in children; manipulation of dosage forms; toxicity and kinetics of excipients in neonates.